|
1
|
Sieper J and Poddubnyy D: Axial
spondyloarthritis. Lancet. 390:73–84. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Braun J and Sieper J: Ankylosing
spondylitis. Lancet. 369:1379–1390. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zink A, Braun J, Listing J and Wollenhaupt
J: Disability and handicap in rheumatoid arthritis and ankylosing
spondylitis - results from the German rheumatological database.
German Collaborative Arthritis Centers. J Rheumatol. 27:613–622.
2000.PubMed/NCBI
|
|
4
|
Boonen A, Chorus A, Miedema H, van der
Heijde D, van der Tempel H and van der Linden S: Employment, work
disability, and work days lost in patients with ankylosing
spondylitis: a cross sectional study of Dutch patients. Ann Rheum
Dis. 60:353–358. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ward MM, Deodhar A, Akl EA, Lui A, Ermann
J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman
RD, et al: American College of Rheumatology/Spondylitis Association
of America/Spondyloarthritis Research and Treatment Network 2015
Recommendations for the Treatment of Ankylosing Spondylitis and
Nonradiographic Axial Spondyloarthritis. Arthritis Care Res
(Hoboken). 68:151–166. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
van der Heijde D, Ramiro S, Landewe R,
Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A,
Dagfinrud H, Dougados M, et al: 2016 update of the ASAS-EULAR
management recommendations for axial spondyloarthritis. Ann Rheum
Dis. 76:978–991. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wanders A, Heijde Dv, Landewé R, Béhier
JM, Calin A, Olivieri I, Zeidler H and Dougados M: Nonsteroidal
antiinflammatory drugs reduce radiographic progression in patients
with ankylosing spondylitis: a randomized clinical trial. Arthritis
Rheum. 52:1756–1765. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Poddubnyy D, Rudwaleit M, Haibel H,
Listing J, Märker-Hermann E, Zeidler H, Braun J and Sieper J:
Effect of non-steroidal anti-inflammatory drugs on radiographic
spinal progression in patients with axial spondyloarthritis:
results from the German Spondyloarthritis Inception Cohort. Ann
Rheum Dis. 71:1616–1622. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Singh G and Triadafilopoulos G:
Epidemiology of NSAID induced gastrointestinal complications. J
Rheumatol Suppl. 56:18–24. 1999.PubMed/NCBI
|
|
10
|
Fosbøl EL, Køber L, Torp-Pedersen C and
Gislason GH: Cardiovascular safety of non-steroidal
anti-inflammatory drugs among healthy individuals. Expert Opin Drug
Saf. 9:893–903. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Song IH, Poddubnyy DA, Rudwaleit M and
Sieper J: Benefits and risks of ankylosing spondylitis treatment
with nonsteroidal antiinflammatory drugs. Arthritis Rheum.
58:929–938. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shau WY, Chen HC, Chen ST, Chou HW, Chang
CH, Kuo CW and Lai MS: Risk of new acute myocardial infarction
hospitalization associated with use of oral and parenteral
non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover
study of Taiwan's National Health Insurance claims database and
review of current evidence. BMC Cardiovasc Disord.
12(4)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shukla A, Rai MK, Prasad N and Agarwal V:
Short-Term Non-Steroid Anti-Inflammatory Drug Use in
Spondyloarthritis Patients Induces Subclinical Acute Kidney Injury:
Biomarkers Study. Nephron. 135:277–286. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Massey T, Derry S, Moore RA and McQuay HJ:
Topical NSAIDs for acute pain in adults. Cochrane Database Syst
Rev. 6(CD007402)2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Derry S, Moore RA and Rabbie R: Topical
NSAIDs for chronic musculoskeletal pain in adults. Cochrane
Database Syst Rev. 9(CD007400)2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mu R, Bao CD, Chen ZW, Zheng Y, Wang GC,
Zhao DB, Hu SX, Li YJ, Shao ZW, Zhang ZY, et al: Efficacy and
safety of loxoprofen hydrogel patch versus loxoprofen tablet in
patients with knee osteoarthritis: a randomized controlled
non-inferiority trial. Clin Rheumatol. 35:165–173. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Garrett S, Jenkinson T, Kennedy LG,
Whitelock H, Gaisford P and Calin A: A new approach to defining
disease status in ankylosing spondylitis: the Bath Ankylosing
Spondylitis Disease Activity Index. J Rheumatol. 21:2286–2291.
1994.PubMed/NCBI
|
|
19
|
van der Heijde D, Lie E, Kvien TK, Sieper
J, Van den Bosch F, Listing J, Braun J and Landewé R; Assessment of
SpondyloArthritis international Society (ASAS): ASDAS, a highly
discriminatory ASAS-endorsed disease activity score in patients
with ankylosing spondylitis. Ann Rheum Dis. 68:1811–1818.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Machado P, Landewé R, Lie E, Kvien TK,
Braun J, Baker D and van der Heijde D; Assessment of
SpondyloArthritis international Society: Ankylosing Spondylitis
Disease Activity Score (ASDAS): defining cut-off values for disease
activity states and improvement scores. Ann Rheum Dis. 70:47–53.
2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Grimes DA, Hubacher D, Nanda K, Schulz KF,
Moher D and Altman DG: The Good Clinical Practice guideline: a
bronze standard for clinical research. Lancet. 366:172–174.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Anderson JJ, Baron G, van der Heijde D,
Felson DT and Dougados M: Ankylosing spondylitis assessment group
preliminary definition of short-term improvement in ankylosing
spondylitis. Arthritis Rheum. 44:1876–1886. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Calin A, Garrett S, Whitelock H, Kennedy
LG, O'Hea J, Mallorie P and Jenkinson T: A new approach to defining
functional ability in ankylosing spondylitis: the development of
the Bath Ankylosing Spondylitis Functional Index. J Rheumatol.
21:2281–2285. 1994.PubMed/NCBI
|
|
24
|
Banning M: The use of topical diclofenac
for pain in osteoarthritis of the knee: a review. Br J Community
Nurs. 11:487–492. 2006.PubMed/NCBI
|
|
25
|
Tugwell PS, Wells GA and Shainhouse JZ:
Equivalence study of a topical diclofenac solution (pennsaid)
compared with oral diclofenac in symptomatic treatment of
osteoarthritis of the knee: a randomized controlled trial. J
Rheumatol. 31:2002–2012. 2004.PubMed/NCBI
|
